Project cooperationUpdated on 21 January 2026
PRE-CLINICAL Industrial/academic partner search
Grants Officer at Axxam SPA
Milano, Italy
About
A developing consortium, under the Call HLTH-2026-01-TOOL-03, is seeking one additional EU- or UK-based partner (SME, industry, or academic institution), preferably non-Italian, that owns at least one small-molecule preclinical oncology candidate (ideally in immuno-oncology) to be advanced towards clinical phases and is willing to collaborate in the design, development, validation, and regulatory assessment of cutting-edge NAMs
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Type
- Consortium/Coordinator seeks Partners
Organisation
Similar opportunities
Project cooperation
Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
SILVIA Cainarca
Scientific Officer at Axxam SPA
Bresso (Milan), Italy
Project cooperation
Seeking collaboration in ATMP and New Approach Methodologies
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
Grzegorz Chodaczek
Immunotherapy Group Leader at Łukasiewicz Research Network - PORT Polish Center for Technology Development
Wrocław, Poland
Project cooperation
Advancing Single-Molecule De-Novo Protein Sequencing
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Til Schlotter
ETH Researcher, Co-founder & CEO at UNOMR AG
Zurich, Switzerland